Table 3.
Demographics, and operative and result data for patients in the pedicled vascularized fibula and massive bone allograft group
| Patient number | Age (years) | Gender | Diagnosis | Site | Resection length (cm) | Fibula length (cm) | Surgery time (hours) | Blood transfusion (units) | Time to full weightbearing (months) | Followup (months) | MSTS (30 points) | Complications | Additional procedure |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 7 | F | Osteosarcoma† | Diaphysis | 10.5 | 13 | 6 | 2 | 6 | 189 | 27 | Nickel allergy | Plate removal |
| 2 | 8 | M | Ewing’s | Diaphysis | 15 | 18 | 4 | 4 | 13 | 37 (DOD) | 27 | Local recurrence | |
| 3 | 8 | M | Ewing’s | Diaphysis | 13.2 | 15 | 4 | 4 | 8 | 84 | 24 | Microfracture (vascularized fibular graft hypertrophy) | |
| 4 | 8 | M | Osteosarcoma | MDP | 10 | 13 | 5.5 | 5 | 8 | 53 | 24 | Microfracture (vascularized fibular graft hypertrophy) | |
| 5 | 10 | F | Adamantinoma | Diaphysis | 9.5 | 12 | 4 | 4 | 7 | 58 | 29 | Valgus | Varus osteotomy, reosteosynthesis |
| 6 | 10 | F | Osteosarcoma | Diaphysis | 14 | 18 | 5 | 2 | NA | 22 | 16 | Fracture attributable to trauma, valgus | Varus osteotomy, reosteosynthesis |
| 7 | 11 | M | Osteosarcoma | MDP MEP | 11 | 17 | 7 | NA | 18 | 133 | 27 | Fracture | Dual onlay allograft reosteosynthesis |
| 8 | 11 | F | Osteosarcoma | MDP MEP | 13.5 | 17 | 7.5 | 7 | 8 | 54 | 7 | Local recurrence | Amputation |
| 9 | 11 | M | Osteosarcoma | MDP MEP | 9 | 12 | 5.5 | NA | 9 | 23 | 24 | Fracture-twice | Conservative |
| 10 | 12 | M | Ewing’s | Diaphysis | 18 | 20 | 6 | 3 | NA | 7 (DOD) | NA | ||
| 11 | 12 | M | Ewing’s | Diaphysis | 11 | 17 | 7 | NA | NA | 8 (DOD) | NA | ||
| 12 | 14 | M | Osteosarcoma | Diaphysis | 13.5 | 17 | 8 | 4 | 14 | 53 (DOD) | 7 | Local recurrence | Amputation |
| 13 | 14 | M | Ewing’s | Diaphysis | 19 | 22 | 4.5 | 3 | 10 | 179 | 28 | Microfracture (vascularized fibular graft hypertrophy) | |
| 14 | 14 | M | Osteosarcoma | MDP MEP | 14.5 | 16 | 7.5 | 4 | 14 | 70 | 29 | Delayed union | Autograft |
| 15 | 15 | M | Ewing’s | Diaphysis | 14 | 17 | 5.30 | 1 | 12 | 209 | 28 | ||
| 16 | 15 | F | Ewing’s | Diaphysis | 17 | 18.5 | 4.5 | 4 | 24 | 151 | 29 | ||
| 17 | 15 | M | Osteosarcoma | Diaphysis | 13 | 18 | 4 | 5 | 7 | 146 | 6 | Deep infection | Implant failure, Ilizarov technique |
| 18 | 15 | M | Ewing’s | MDP | 13 | 14 | 5.5 | 5 | 11 | 68 | 27 | ||
| 19 | 16 | M | Osteosarcoma | MDP MEP | 11 | 18 | 7 | NA | 7 | 48 | 28 | ||
| 20 | 17 | F | Osteosarcoma | Diaphysis | 20.5 | 24 | 6 | 4 | 20 | 188 | 28 | Fracture (vascularized fibular graft hypertrophy) | Reosteosynthesis |
| 21 | 17 | M | Osteosarcoma | MDP MEP | 15.5 | 18 | 6.5 | 6 | 11 | 64 | 29 | Microfracture (vascularized fibular graft hypertrophy) | |
| 22 | 22 | F | Adamantinoma | Diaphysis | 19.5 | 17 | 3.25 | 2 | 8 | 18 | 30 | ||
| 23 | 23 | M | Adamantinoma | Distal diaphysis | 17 | 19 | 7 | 2 | 8 | 48 | 30 | ||
| 24 | 31 | M | Ewing’s | Diaphysis | 21 | 25 | 6 | 8 | 15 | 203 | 30 | ||
| 25 | 38 | M | Osteosarcoma† | Diaphysis | 17 | 18 | 5.5 | 3 | 14 | 91 | 25 | Valgus, implant failure (vascularized fibular graft hypertrophy) | Reosteosynthesis |
†Low-grade osteosarcoma–no chemotherapy; MDP = metadiaphysal; MEP = metaepiphyseal; DOD = died of disease; VF = vascularized fibula; NA = not available.